Cell and Gene Therapy Market to Grow by USD 6.56 Billion (2024-2028), Driven by Rising Prevalence of Chronic Diseases, AI-Powered Report Explores Market Evolution - Technavio [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating.
Antisense & RNAi Therapeutics Market Overview 2024-2030 - Global Antisense & RNAi Therapeutics Market Forecast to Reach $14.4 Billion by 2030 [Yahoo! Finance]
RFK Jr. could play a big role under Trump—and Big Pharma is sounding the alarm: ‘We need somebody grounded by science and evidence, not somebody who rejects it' [Yahoo! Finance]
RFK Jr. could play a big role under Trump—and Big Pharma is sounding the alarm: ‘We need somebody grounded by science and evidence, not somebody who rejects it' [Fortune]